Trial Profile
Prospective Randomized Multicenter Phase II Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms NEOLAP
- 14 Dec 2021 Status changed from active, no longer recruiting to completed.
- 21 Sep 2021 Results presented at the 46th European Society for Medical Oncology Congress
- 05 Mar 2020 This trial has been completed in Germany, according to European Clinical Trials Database record.